Here, we publish important new scientific research and materials, discuss significant NGP category developments in the media, report on scientific conferences we’ve attended, and more. Please note not all of this content is available in certain territories.
Imperial Brands/Reemtsma Germany attended the Endoprothetik-Congress of Charité Berlin conference as industry sponsor and speaker. Senior Cluster Officer, Scientific and Regulatory Affairs DACH & Nordics, Dr Thomas Nahde reports on the virtual event. Imperial Brands through its Reemtsma Germany subsidiary for the first time attended this year’s Endoprothetik-Congress annually hosted by the Charité Berlin, […]
24 Mar 2021
Scientific Digital Communications Editor Arran Frood details the latest research findings at Imperial Brands. 17 March 2021, Bristol – A new peer-reviewed study published in the journal Toxicological Research & Application shows acute exposure of a 3D human bronchial tissue model to e-cigarette aerosol has minimal impact on gene expression compared to smoke from […]
17 Mar 2021
Nicotine continues to be fundamentally misunderstood, even among adult smokers. In this new video blog, we explain why its perception should match the current scientific evidence. “People smoke for the nicotine but they die from the tar.” So proclaimed Professor Michael Russell, Tobacco Harm Reduction’s (THR) earliest proponent, in 1976. Yet almost half a […]
9 Feb 2021
Principal Toxicologist Dr Liam Simms explains why Imperial Brands has embraced Toxicity Testing in the 21st Century (TT21C). What is TT21C all about? Liam Simms: TT21C – or Toxicity Testing in the 21st Century – is essentially a blueprint for the future of toxicity testing within regulatory frameworks and for product stewardship assessments. A […]
26 Jan 2021
A notable review into e-cigarettes, the Cochrane Review, has turned its eyes to electronic vapour products (EVPs). Christopher Wood examines the findings and what it means for tobacco harm reduction policy and research. Cochrane Reviews are systematic literature reviews of research in health care and health policy. They are carried out by independent subject […]
20 Jan 2021
Abid Khan-Lodhi – Next Generation Product (NGP) Innovation Director at Nerudia – spoke to Italian publication Panorama about the company’s innovation philosophy, and the development process behind Imperial’s portfolio of potentially harm reduced NGPs. Read the original article here (in Italian, web browsers such as Google Chrome can auto translate), and excerpts below. Panorama: Can you […]
6 Jan 2021
